These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15947891)

  • 1. The mineralocorticoid receptor and oxidative stress.
    Fiebeler A; Luft FC
    Heart Fail Rev; 2005 Jan; 10(1):47-52. PubMed ID: 15947891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
    Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
    Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.
    Queisser N; Schupp N
    Free Radic Biol Med; 2012 Jul; 53(2):314-27. PubMed ID: 22609249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone and inflammation.
    Gilbert KC; Brown NJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):199-204. PubMed ID: 20422780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular actions of aldosterone.
    Briet M; Schiffrin EL
    J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone as a cardiovascular risk hormone.
    Yoshimoto T; Hirata Y
    Endocr J; 2007 Jun; 54(3):359-70. PubMed ID: 17409575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin-aldosterone and bone metabolism].
    Ikeda K
    Clin Calcium; 2014 Jun; 24(6):885-91. PubMed ID: 24870840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
    Funder JW
    Am J Cardiovasc Drugs; 2007; 7(3):151-7. PubMed ID: 17610342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy.
    Touyz RM; Callera GE
    Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282
    [No Abstract]   [Full Text] [Related]  

  • 12. [Respective roles of cortisol, aldosterone and angiotensin II during pathophysiology of atherosclerosis].
    Ayari H
    Ann Biol Clin (Paris); 2013; 71(4):381-8. PubMed ID: 23906564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.
    McCurley A; McGraw A; Pruthi D; Jaffe IZ
    Pflugers Arch; 2013 Dec; 465(12):1661-70. PubMed ID: 23636772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II: a devious activator of mineralocorticoid receptor-dependent gene expression.
    Blaxall BC; Miano JM; Berk BC
    Circ Res; 2005 Apr; 96(6):610-1. PubMed ID: 15802618
    [No Abstract]   [Full Text] [Related]  

  • 15. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy.
    Ambroisine ML; Milliez P; Nehme J; Pasquier AL; De Angelis N; Mansier P; Swynghedauw B; Delcayre C
    Diabetes Metab; 2004 Sep; 30(4):311-8. PubMed ID: 15525873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of the mineralocorticoid receptor in cardiac and vascular remodeling.
    Fiebeler A; Haller H
    Nephron Physiol; 2003; 94(3):p47-50. PubMed ID: 12902615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone: effects on the kidney and cardiovascular system.
    Briet M; Schiffrin EL
    Nat Rev Nephrol; 2010 May; 6(5):261-73. PubMed ID: 20234356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central mineralocorticoid receptors and the role of angiotensin II and glutamate in the paraventricular nucleus of rats with angiotensin II-induced hypertension.
    Gabor A; Leenen FH
    Hypertension; 2013 May; 61(5):1083-90. PubMed ID: 23509081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone in vascular and metabolic dysfunction.
    Luther JM
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.